FAM9B: A Drug Target / Disease Biomarker (G171483)

Target Name: FAM9B

NCBI ID: G171483

FAM9B

FAM9B: A Drug Target / Disease Biomarker

FAM9B, also known as FAM9B1, is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The FAM9B gene is located on chromosome 16 and encodes a protein known as FAM9B, which is a member of the FAM family of proteins. The FAM family is characterized by the presence of a conserved domain known as the FAM-1 domain, which is responsible for the protein's structure and function.

Studies have shown that the FAM9B gene is involved in a wide range of physiological processes in the body, including cell signaling, DNA repair, and metabolism. Additionally, the FAM9B gene has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of the FAM9B gene as a drug target is its druggable nature. Researchers have identified several potential drug compounds that can interact with the FAM9B protein and have shown that these compounds can inhibit its activity, leading to a reduction in the growth or progression of cancer cells, neurodegenerate tissues, or autoimmune disorders.

Another promising aspect of the FAM9B gene is its potential as a biomarker. The FAM9B protein is expressed in a wide range of tissues and cells in the body, making it a potential marker for disease diagnosis and monitoring. This is especially important for cancer, where the FAM9B protein is often overexpressed and can be used as a diagnostic marker for the disease.

In addition to its potential as a drug target or biomarker, the FAM9B gene is also of interest to researchers because of its role in the development of cancer. Studies have shown that the FAM9B gene is frequently deleted or mutated in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting the FAM9B gene may be an effective way to develop new, more targeted treatments for these diseases.

Overall, the FAM9B gene is a promising drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in the development and progression of cancer and other diseases, as well as its potential as a diagnostic marker.

Protein Name: Family With Sequence Similarity 9 Member B

The "FAM9B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM9B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets